🔴 Context Therapeutics is trading 6.73% down today as the specific cause remains unclear

Context Therapeutics is trading 6.73% down now at $0.46, with the specific cause unclear and no confirmed company-specific announcement dated August 19, 2026.

• The latest reported update was the August 5 second-quarter release, which prioritized CTIM-76 and CT-202 while discontinuing CT-95 development.
• Broader U.S. equities and biotech are trading higher.
• The decline may reflect continued post-earnings selling or stock-specific pressure, but available evidence does not support a definitive attribution.